Stock Research for THRX

THRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

THRX Stock Chart & Research Data

The THRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the THRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


THRX Due diligence Resources & Stock Charts

The THRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View THRX Detailed Price Forecast - CNN Money CNN View THRX Detailed Summary - Google Finance
Yahoo View THRX Detailed Summary - Yahoo! Finance Zacks View THRX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View THRX Trends & Analysis - Trade-Ideas Barrons View THRX Major Holders - Barrons
NASDAQ View THRX Call Transcripts - NASDAQ Seeking View THRX Breaking News & Analysis - Seeking Alpha
Spotlight View THRX Annual Report - CompanySpotlight.com OTC Report View THRX OTC Short Report - OTCShortReport.com
TradeKing View THRX Fundamentals - TradeKing Charts View THRX SEC Filings - Bar Chart
WSJ View Historical Prices for THRX - The WSJ Morningstar View Performance/Total Return for THRX - Morningstar
MarketWatch View the Analyst Estimates for THRX - MarketWatch CNBC View the Earnings History for THRX - CNBC
StockMarketWatch View the THRX Earnings - StockMarketWatch MacroAxis View THRX Buy or Sell Recommendations - MacroAxis
Bullish View the THRX Bullish Patterns - American Bulls Short Pains View THRX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View THRX Stock Mentions - StockTwits PennyStocks View THRX Stock Mentions - PennyStockTweets
Twitter View THRX Stock Mentions - Twitter Invest Hub View THRX Investment Forum News - Investor Hub
Yahoo View THRX Stock Mentions - Yahoo! Message Board Seeking Alpha View THRX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for THRX - SECform4.com Insider Cow View Insider Transactions for THRX - Insider Cow
CNBC View THRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for THRX - OTC Markets
Yahoo View Insider Transactions for THRX - Yahoo! Finance NASDAQ View Institutional Holdings for THRX - NASDAQ


Stock Charts

FinViz View THRX Stock Insight & Charts - FinViz.com StockCharts View THRX Investment Charts - StockCharts.com
BarChart View THRX Stock Overview & Charts - BarChart Trading View View THRX User Generated Charts - Trading View




Latest Financial News for THRX


Theseus Pharmaceuticals Announces Closing of Tender Offer
Posted on Wednesday February 14, 2024

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies, today announced that Concentra Biosciences, LLC ("Concentra") through its wholly owned subsidiary, Concentra Merger Sub II, Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding


Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals
Posted on Tuesday January 30, 2024

SAN DIEGO, January 30, 2024--As previously announced on December 22, 2023, Concentra Biosciences, LLC ("Parent") and its wholly owned subsidiary, Concentra Merger Sub II, Inc. ("Purchaser"), entered into a merger agreement (the "Merger Agreement") with Theseus Pharmaceuticals, Inc. (Nasdaq: THRX) ("Theseus") whereby Purchaser will acquire Theseus for a price per share of Theseus common stock ("Theseus common stock") between $3.90 and $4.05 in cash, consisting of (i) a base cash price of $3.90 pe


Is Theseus Pharmaceuticals (THRX) Stock a Solid Choice Right Now?
Posted on Friday December 29, 2023

Theseus Pharmaceuticals (THRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.


Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
Posted on Friday December 22, 2023

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies, today announced it has entered into a definitive merger agreement (the "Merger Agreement") whereby Concentra Biosciences, LLC ("Concentra") will acquire Theseus for a price per share of Theseus common stock ("Theseus common stock") of b


Stock Market & Investing Books

Enter a stock symbol to view the stock details.